Acneiform eruption in a patient receiving bevacizumab for glioblastoma multiforme.
Keenan
Bridget P
BP
Abuav
Rachel
R
D017486:Acneiform Eruptions / Q000139:chemically induced* / Q000175:diagnosis; D000328:Adult; D020533:Angiogenesis Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D001932:Brain Neoplasms / Q000188:drug therapy; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology; D005909:Glioblastoma / Q000188:drug therapy; D006801:Humans; D008297:Male; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab